NCT00590382 is a clinical trial of AMPLATZER Muscular VSD Occluder in Muscular, sponsored by Abbott Medical Devices.

Who is sponsoring NCT00590382?

NCT00590382 is sponsored by Abbott Medical Devices.

What drugs are being tested in NCT00590382?

Interventions in NCT00590382: AMPLATZER Muscular VSD Occluder.

What condition does NCT00590382 study?

NCT00590382 studies Muscular, Ventricular, Septal, Defects, VSD.

Is NCT00590382 still recruiting?

NCT00590382 is currently approved for marketing. Last updated 4 February 2019.

Last reviewed 2019-02-04 · How we verify

NCT00590382

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Emergency/Compassionate Use - Muscular VSD Occluder

APPROVED FOR MARKETING Last updated 4 February 2019

What this trial tests

trial testing AMPLATZER Muscular VSD Occluder in Muscular. Approved for marketing.

Quick facts

Lead sponsor	Abbott Medical Devices
Status	APPROVED FOR MARKETING
Study type	EXPANDED_ACCESS

Drugs / interventions tested

AMPLATZER Muscular VSD Occluder

Conditions studied

Muscular — all drugs for Muscular →
Ventricular — all drugs for Ventricular →
Septal — all drugs for Septal →
Defects — all drugs for Defects →

Sponsor

Abbott Medical Devices — full company profile →

Who can join

Eligibility, any sex, with Muscular or Ventricular. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Expanded access to the AMPLATZER Muscular VSD Occluder

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Compassionate use of drugs and medical devices in the United States, the European Union and Japan.
Tsuyuki K, Yano K, Watanabe N, Aruga A, et al · · 2016 · cited 13× · PMID 31245484 · DOI 10.1016/j.reth.2015.11.002

Verify or expand the search:

Other Abbott Medical Devices trials

Trials by the same sponsor.

NCT07421076 — Grid eXplore Mapping Study · NA · recruiting
NCT07509658 — TriClip Japan Post-Approval Study · recruiting
NCT07361445 — Agilis RF TSP Early Feasibility Study · NA · recruiting
NCT07373353 — A Clinical Evaluation of AMJ-401 · NA · recruiting
NCT07217392 — Left Bundle Branch Area Pacing (LBBAP) PMCF Study · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT00590382 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Abbott Medical Devices
Last refreshed: 4 February 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00590382.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing